Delivery Order SPE2DB20D2014-SPE2DB23FC79H
Award Date 7/20/23
Potential Completion Date 7/21/23
Potential Value $54K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $33,482.64 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by September 6, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order...
- The Defense Logistics Agency awarded a $43,857.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the product to a location in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order for...
- The Defense Logistics Agency awarded a $43,565.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under this single award, Amerisourcebergen will deliver approximately 2,000 pens of the drug to a facility in Conshohocken, Pennsylvania over a one day period in late July 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order from its corporate offices to...
- The Defense Logistics Agency awarded a $3,097.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by September 13, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, suggesting this order relates...
- The Defense Logistics Agency awarded a $118,039.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of DUPIXENT 300 MG/2 ML pens. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 2ML DUPIXENT pens to a facility in Conshohocken, Pennsylvania by September 18, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed by the DLA, the agency responsible for...
- The Defense Logistics Agency awarded a $17,338 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will supply the biologic drug to the DLA under a one-day period of performance in Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company. No subcontractors or set aside designations were indicated. The DLA manages the global supply chain for the Department of Defense, procuring all...
- The Defense Logistics Agency awarded a $29,742 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under the terms of the firm fixed price contract, Amerisourcebergen will provide the specified pharmaceutical products to the DLA by August 9, 2023 from its facility in Conshohocken, Pennsylvania. As a leading provider of medical supplies to the Department of Defense, the DLA relies on contracts such as these with major distributors including Amerisourcebergen...
- The Defense Logistics Agency awarded a $10,801 delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Under the terms of the firm fixed price contract, Amerisourcebergen will provide the specified pharmaceutical product to the DLA by September 8, 2023 from its facility in Conshohocken, Pennsylvania. As a leading provider of medical supplies to the Department of Defense, the DLA relies on contracts such as these with major distributors including Amerisourcebergen...
- The Defense Logistics Agency awarded a $12,163.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. As the prime contractor, Amerisourcebergen will deliver the medication to a location in Conshohocken, Pennsylvania by August 16, 2023 in support of DLA procurement programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order is likely fulfilling...
- The Defense Logistics Agency awarded a $11,765.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. The order is for 2ML pens of DUPIXENT, which is used to treat atopic dermatitis and asthma. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by August 31, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FC79HDelivery Order
The Defense Logistics Agency awarded a $54,454.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for DUPIXENT 300 MG/2 ML pens. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will deliver the medication to a location in Conshohocken, Pennsylvania by July 21, 2023 in support of DLA programs. No set aside designation or subcontractors were identified. DLA facilitates supply chain management for the Department of Defense, so this order for DUPIXENT, which treats atopic dermatitis and asthma, will likely support medical readiness for military service members.
Generated 12/22/23, 3:12 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.5k | 7/20/23 |